Biotech RadarJobs updated

COMPANY

NX Development

nxdevcorp.com ↗

Clinical Phase 3

Profile checked Oct 10, 2026

Keywords: Ovarian Cancer Meningioma Gleolan

2Trials (company is sponsor)

Timeline

  1. Trial start Phase 3: Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) source ↗
  2. Trial start Phase 3: Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT05804370Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)Phase 3RecruitingMay 30, 20242028-09 (estimated)
NCT04305470Gleolan for Visualization of Newly Diagnosed or Recurrent MeningiomaPhase 3CompletedOct 28, 2020Nov 7, 2022 (actual)
Feedback